← Eichor
Study identifier: NCT06723626 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of Intravenous Metabolic Recovery Agent in Elderly Septic Patients on Prognosis and Microcirculation.

Condition: Septic Shock  ·  Sponsor: Southeast University, China

PhaseNA
Planned participants40
Who can joinAll sexes, 60 Years to 85 Years
Healthy volunteersNo

About this study

This study intends to observe the effect of intravenous hydrocortisone combined with vitamin C and vitamin B1 infusion on the prognosis and sublingual microcirculation in patients with sepsis or septic shock through a prospective randomized controlled study method.

This description comes directly from the study's public registry record.

Talk to the study team

Jingyuan Xu, M.D.  ·  8602583262550  ·  xujingyuanmail@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Zhongda Hospital Southeast UniversityNanjing, Jiangsu, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06723626